Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: A 13-year cause-specific multivariate mortality study

Alzheimer's Research and Therapy

Volumn 6, Issue 4, 2014, Pages

  Nägga, Katarina ^a   Wattmo, Carina ^a   Zhang, Yi ^b   Wahlund, Lars Olof ^b   Palmqvist, Sebastian ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; VASCULAR CELL ADHESION MOLECULE 1;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CEREBRAL INFLAMMATION; CEREBROSPINAL FLUID; COGNITION; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEX; WHITE MATTER LESION;

EID: 84903676861     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt271     Document Type: Article

References (53)

1. Prognosis with dementia in Europe: a collaborative study of population-based cohorts: Neurologic Diseases in the Elderly Research Group. Jagger C, Andersen K, Breteler MM, Copeland JR, Helmer C, Baldereschi M, Fratiglioni L, Lobo A, Soininen H, Hofman A, Launer LJ, Neurology 2000 54 16 S20
2. Risk of death among persons with Alzheimer's disease: a national register-based nested case-control study. Lonnroos E, Kyyronen P, Bell JS, van der Cammen TJ, Hartikainen S, J Alzheimers Dis 2013 33 157 164
3. Alzheimer disease and mortality: a 15-year epidemiological study. Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST, Arch Neurol 2005 62 779 784 (Pubitemid 40656094)
4. Survival of ethnic Chinese with Alzheimer's disease: a 5-year longitudinal study in Taiwan. Tsai PH, Chen SP, Lin KN, Wang PN, Wang HC, Liu CY, Hong CJ, Liu HC, J Geriatr Psychiatry Neurol 2007 20 172 177
5. Lethality of Alzheimer disease and its impact on nursing home placement. Arrighi HM, Neumann PJ, Lieberburg IM, Townsend RJ, Alzheimer Dis Assoc Disord 2010 24 90 95
6. Alzheimer's disease facts and figures. Association As, Alzheimers Dement 2012 8 131 168
7. Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. Aguero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B, J Clin Epidemiol 1999 52 737 743 (Pubitemid 29361449)
8. Predictors of nursing home admission and/or death in incident Alzheimer's disease and other dementia cases compared to controls: a population-based study. Eaker ED, Vierkant RA, Mickel SF, J Clin Epidemiol 2002 55 462 468 (Pubitemid 34462242)
9. Survival following a diagnosis of Alzheimer disease. Brookmeyer R, Corrada MM, Curriero FC, Kawas C, Arch Neurol 2002 59 1764 1767 (Pubitemid 35340487)
10. Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Helzner EP, Scarmeas N, Cosentino S, Tang MX, Schupf N, Stern Y, Neurology 2008 71 1489 1495
11. Death certification in treated cases of presenile Alzheimer's disease and vascular dementia in Scotland. Thomas BM, Starr JM, Whalley LJ, Age Ageing 1997 26 401 406 (Pubitemid 27448385)
12. Factors associated with mortality in patients with early-onset Alzheimer's disease: a five-year longitudinal study. Ueki A, Shinjo H, Shimode H, Nakajima T, Morita Y, Int J Geriatr Psychiatry 2001 16 810 815 (Pubitemid 32834119)
13. Cause of death in patients with dementia disorders. Brunnstrom HR, Englund EM, Eur J Neurol 2009 16 488 492
14. Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Mölsä PK, Marttila RJ, Rinne UK, Acta Neurol Scand 1986 74 103 107 (Pubitemid 16016605)
15. Death in dementia: a study of causes of death in dementia patients and their spouses. Ryan D, Int J Geriatr Psychiatry 1992 7 465 472
16. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Iadecola C, Acta Neuropathol 2010 120 287 296
17. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ, Lancet Neurol 2013 12 207 216
18. Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D, Alzheimers Res Ther 2010 2 1
19. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, Barroeta-Espar I, Fernandez-Carballo L, de Munain EL, Perez J, Marquie M, Serrano-Pozo A, Frosch MP, Lowe V, Parisi JE, Petersen RC, Ikonomovic MD, Lopez OL, Klunk W, Hyman BT, Gomez-Isla T, Brain 2013 136 2510 2526
20. Soluble adhesion molecules and angiotensin-converting enzyme in dementia. Nielsen HM, Londos E, Minthon L, Janciauskiene SM, Neurobiol Dis 2007 26 27 35 (Pubitemid 46436485)
21. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, Neurology 1984 34 939 944 (Pubitemid 14076461)
22. World Health Organization, Manual of the International Statistical Classification of Diseases and Health Related Problems. 10th revision Geneva, Switzerland: World Health Organization 1992
23. Simultaneous measurement of beta-amyloid (1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K, Clin Chem 2005 51 336 345 (Pubitemid 40175803)
24. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Blennow K, Hampel H, Weiner M, Zetterberg H, Nat Rev Neurol 2010 6 131 144
25. A new rating scale for age-related white matter changes applicable to MRI and CT. Wahlund L, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P, Stroke 2001 32 1318 1322 (Pubitemid 32530416)
26. Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer's disease. Palmqvist S, Sarwari A, Wattmo C, Bronge L, Zhang Y, Wahlund LO, Nagga K, Dement Geriatr Cogn Disord 2011 32 417 423
27. Progression of atrophy in Alzheimer's disease and related disorders. Whitwell JL, Neurotox Res 2010 18 339 346
28. Usefulness of computed tomography linear measurements in diagnosing Alzheimer's disease. Zhang Y, Londos E, Minthon L, Wattmo C, Liu H, Aspelin P, Wahlund LO, Acta Radiol 2008 49 91 97
29. "Mini-mental state:" a practical method for grading the cognitive state of patients for the clinician. Folstein MF, Folstein SE, McHugh PR, J Psychiatr Res 1975 12 189 198
30. Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease. Eikelenboom P, Hoozemans JJ, Veerhuis R, van Exel E, Rozemuller AJ, van Gool WA, Alzheimers Res Ther 2012 4 15
31. Deciphering the mechanism underlying late-onset Alzheimer disease. Krstic D, Knuesel I, Nat Rev Neurol 2013 9 25 34
32. Local neuroinflammation and the progression of Alzheimer's disease. McGeer PL, McGeer EG, J Neurovirol 2002 8 529 538 (Pubitemid 36104718)
33. Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander? Tan ZS, Seshadri S, Alzheimers Res Ther 2010 2 6
34. Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. Krstic D, Madhusudan A, Doehner J, Vogel P, Notter T, Imhof C, Manalastas A, Hilfiker M, Pfister S, Schwerdel C, Riether C, Meyer U, Knuesel I, J Neuroinflamm 2012 9 151
35. Inflammation and disability as risk factors for mortality in elderly acute care patients. Forasassi C, Golmard JL, Pautas E, Piette F, Myara I, Raynaud-Simon A, Arch Gerontol Geriatr 2009 48 406 410
36. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Henneman WJ, Sluimer JD, Cordonnier C, Baak MM, Scheltens P, Barkhof F, van der Flier WM, Stroke 2009 40 492 498
37. MMSE for survival prognostics in dementia. Hotte SD, Lankers D, Kissler S, Freyberger HJ, Schroder SG, Psychiatr Prax 2010 37 78 83
38. Survival after initial diagnosis of Alzheimer disease. Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA, Ann Intern Med 2004 140 501 509
39. Survival of outpatients with Alzheimer-type dementia. Walsh JS, Welch HG, Larson EB, Ann Intern Med 1990 113 429 434 (Pubitemid 20333450)
40. Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease. Musicco M, Salamone G, Caltagirone C, Cravello L, Fadda L, Lupo F, Mosti S, Perri R, Palmer K, Dement Geriatr Cogn Disord 2010 30 219 228
41. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Devanand D, Honig L, Marder K, Bell K, Wegesin D, Blacker D, Stern Y, Arch Neurol 2005 62 1601 1608 (Pubitemid 41434568)
42. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. Schneider LS, Dagerman KS, Insel P, JAMA 2005 294 1934 1943 (Pubitemid 41464695)
43. Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia. Brodaty H, Seeher K, Gibson L, Int Psychogeriatr 2012 24 1034 1045
44. Reporting dementia on the death certificates of nursing home residents dying with end-stage dementia. Wachterman M, Kiely DK, Mitchell SL, JAMA 2008 300 2608 2610
45. Adhesion molecule levels in serum and cerebrospinal fluid in children with bacterial meningitis and sepsis. Jaber SM, Hamed EA, Hamed SA, J Pediatr Neurosci 2009 4 76 85
46. Critical role of the alpha 4 integrin/VCAM-1 pathway in cerebral leukocyte trafficking in lupus-prone MRL/fas(lpr) mice. James WG, Bullard DC, Hickey MJ, J Immunol 2003 170 520 527 (Pubitemid 36026179)
47. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. Oh JW, Van Wagoner NJ, Rose-John S, Benveniste EN, J Immunol 1998 161 4992 4999 (Pubitemid 28492081)
48. Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis. Rieckmann P, Altenhofen B, Riegel A, Kallmann B, Felgenhauer K, Mult Scler 1998 4 178 182 (Pubitemid 28410047)
49. Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Singh RJ, Mason JC, Lidington EA, Edwards DR, Nuttall RK, Khokha R, Knauper V, Murphy G, Gavrilovic J, Cardiovasc Res 2005 67 39 49 (Pubitemid 40798291)
50. Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica. Uzawa A, Mori M, Masuda S, Kuwabara S, Arch Neurol 2011 68 913 917
51. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS, J Clin Invest 2001 107 1255 1262 (Pubitemid 32494542)
52. Vascular inflammation in cerebral small vessel disease. Rouhl RP, Damoiseaux JG, Lodder J, Theunissen RO, Knottnerus IL, Staals J, Henskens LH, Kroon AA, de Leeuw PW, Tervaert JW, van Oostenbrugge RJ, Neurobiol Aging 2012 33 1800 1806
53. Rate of cognitive decline and mortality in Alzheimer's disease. Hui JS, Wilson RS, Bennett DA, Bienias JL, Gilley DW, Evans DA, Neurology 2003 61 1356 1361 (Pubitemid 37463370)